The report finds that the combined impact of actual 2026 Medicare Part D negotiated drug prices and expected 2027 prices ...
The average LTC pharmacy will see its operating margin decline 35% by 2027, thanks to the financial effects of Medicare’s ...
QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...
IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a biotech/life ...
Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum ...
22d
LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced the appointment of James Rawls, P ...
Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and ...
Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...
The transaction marks a significant consolidation move within India’s pharmaceutical sector, signaling growing momentum for strategic mergers and acquisitions in the healthcare industry.
The company's board meeting is also set, which will not only approve the standalone and consolidated earnings but also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback